Erlocip (Erlotinib) Tablet is a targeted cancer therapy used in the treatment of non-small cell lung cancer (NSCLC) and advanced pancreatic cancer. It works by inhibiting epidermal growth factor receptor (EGFR) tyrosine kinases, slowing the growth and spread of cancer cells. Trusted medical resources like Mayo Clinic and FDA provide detailed insights into its clinical use and approval.

Key Benefits & Uses

• Helps manage non-small cell lung cancer (NSCLC).

• Effective in treating advanced pancreatic cancer.

• Targets cancer cells specifically, reducing damage to healthy cells.

• Slows down tumor progression and improves survival rates.

• Backed by studies from PubMed and WHO.

How to Use

• Take Erlocip on an empty stomach (1 hour before or 2 hours after meals).

• Dosage is prescribed by your doctor based on medical condition.

• Avoid smoking, as it can reduce the effectiveness of the drug.

• For detailed instructions, visit Drugs.com or WebMD.

Important Safety Information

• Not recommended during pregnancy or breastfeeding.

• Inform your doctor about liver/kidney conditions or if taking other medicines.

• Regular blood tests may be required to monitor treatment.

• Learn more about precautions at Healthline.

Common Side Effects

• Skin rash, dryness, or itching

• Diarrhea and nausea

• Loss of appetite

• Fatigue and weakness

• Eye irritation

(Seek medical help immediately if experiencing severe lung or liver issues.)

Why Choose Erlocip (Erlotinib) Tablet?

• Clinically proven and FDA-approved treatment option.

• Trusted by oncologists worldwide.

• Backed by global health authorities like WHO.

• Offers targeted therapy with fewer risks to healthy cells.